Pegcetacoplan, a targeted C3/C3b inhibitor, shows sustained, robust effects on key markers of kidney disease in patients with C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), according to 52-week results from the VALIANT trial. The 26-week results, which were presented last October at Kidney Week 2024, showed a highly significant difference in change in proteinuria from baseline, as measured by the urine protein-to-creatinine ratio (uPCR); the reduction was 67.2% with pegcetacoplan vs 2.9% with placebo (P < .0001). The current findings showed that not only were these benefits sustained in patients who remained on pegcetacoplan, patients who switched from placebo to pegcetacoplan also experienced reductions of similar magnitude, said Fadi Fakhouri, MD, of Lausanne University Hospital and the University of Lausanne, Switzerland. Fakhouri presented the 1-year results at the 62nd European Renal Association (ERA) Congress 2025. VALIANT Open-Label Period The phase 3 VALIANT trial involved 124 patients with ...
Ardent Health is deploying virtual nurse technology to ease workflow burdens on bedside nurses by offloading routine tasks — and its nurse turnover rate has dropped from 15.5% to 9.5%. The health system is also using virtual specialty consults to enhance care in rural hospitals, cutting unnecessary transfers by 85% and enabling more patients to receive quality care close to home. In this day and age, hospitals can no longer afford to overlook workflow improvement, according to FJ Campbell, chief medical officer at Ardent Health(Opens in a new window). He pointed this out during an interview last month at the Reuters Digital Health conference(Opens in a new window) in Nashville, noting that the pandemic highlighted just how overwhelming hospital workflows can be. The fragmented, cumbersome nature of these workflows led to high levels of staff burnout and turnover, as well as unsustainable reliance on contract labor, Campbell explained. “We needed ...
On June 8, Yuandong Bio(688513) announced that the company recently won the 25th China Patent Excellence Award in recognition of its invention patent for bisoprolol fumarate tablets (Sulele®) “a bisoprolol fumarate I crystal form and its preparation method”. This award was sponsored by the State Intellectual Property OfficeThe Bureau and the World Intellectual Property Organization jointly organized the company’s innovative drugIt is a high recognition of the efforts made in biological research and development and intellectual property protection. This award is not expected to have a significant impact on the company’s current operating performance, but it demonstrates the drug’s significant advantages in terms of technological advancement, innovation and clinical value. In the future, the company will continue to strengthen its patent layout and strive to develop more high-quality innovative drugs . In the first quarter of 2025, Yuandong Bio achieved revenue of 306 million yuan and net profit attributable to ...
Nuotai Biotechnology, on the evening of June 6, the company announced that it had entered into an agreement with Nanjing Novozymes Biotech Co., Ltd. (hereinafter referred to as ” Novozyme “) recently signed the ” Synthetic Biology” in Nanjing Based on the synthetic biology technology platform and combining cross-cutting technologies such as organic synthesis and chemical processes, the two parties will jointly promote technological progress and project cooperation in the field of synthetic biology . The company plans to jointly establish a biopharmaceutical company with Novagen , with the company holding 51% and Novagen holding 49%. After the establishment of the joint venture, it will be included in the company’s consolidated financial statements, and will serve as a platform for subsequent cooperation and specific business. The specific investment scale, construction plan and other matters of the cooperation project will be separately agreed upon by both parties and the internal review ...
Guangxi Dashenlin Shenliu Comprehensive Clinic Co., Ltd. was established, with Pan Guolu as the legal representative, and a registered capital of RMB 1 million. Its business scope includes: medical services; Drug retail; Class III medical devices business operation; Food Internet sales; Medical device Internet information services; traditional Chinese medicine decoction service; medical beauty services, etc. Qichacha’s equity penetration shows that the company is indirectly wholly owned by Dasanlin . https://finance.eastmoney.com/a/202506093425405622.html
Johnson & Johnson, it was announced today that Tenoyada (gusekizumab injection (intravenous infusion)) has been launched in China for the treatment of adult patients with moderately to severely active Crohn’s disease and ulcerative colitis who have had an inadequate response, loss of response, or intolerance to traditional treatments or biologics. Tenoyada (gusekizumab injection (intravenous infusion)) was approved in February this year for the induction treatment of moderately to severely active Crohn’s disease and in April for the induction treatment of ulcerative colitis. Tenoyada (gusekizumab injection) was approved in 2019 for the treatment of psoriasis, and in February this year, it was expanded to maintenance treatment of moderately to severely active Crohn’s disease, and in April, it was expanded to maintenance treatment of ulcerative colitis. Over the past few decades, the incidence of Crohn’s disease and ulcerative colitis in China has continued to rise, and the peak age of onset has ...
Organiser: China Medical and Healthcare Industry Association, Chinese Medical Exchange Association Time:September 17-19, 2025 address:No. 6, North Third Ring East Road, Chaoyang District, Beijing Exhibition hall: China International Exhibition Center (Chaoyang Hall) Product range: Medical Imaging: CT, DR, Radiography Systems, Ultrasound Diagnostic Equipment, MRI Devices, Tumor Therapy Machines, Medical Films, and Processing Systems, etc. Remote and Mobile Intelligent Monitoring Medical Devices: Sleep Monitors, Remote ECG, Blood Pressure, Blood Oxygen, and Body Temperature Monitoring Devices, Cloud Blood Pressure Monitors, Bluetooth Blood Glucose and Blood Pressure Monitors, Wearable Medical Devices, and Health Huts, etc. Diagnostic and Therapeutic Equipment: Endoscopy Systems, ENT Instruments, Dynamic Analysis Instruments, Cryogenic Freezing Equipment, Dialysis Treatment Devices, Surgical Instruments, Electrosurgical Units and Consumables, Staplers, Laser Surgical Instruments, Ultrasound Surgery Equipment, etc. Ward Care Equipment and Appliances: Beds, Carts, Tables, Cabinets, Racks, etc. Disinfection Products: Medical Air Disinfectors, Vacuum Sterilizers, Ultrasonic Cleaning Systems, Disinfectants, etc. Auxiliary Products: Rehabilitation Equipment, ...
The American College of Rheumatology (ACR) has released a summary of a guideline with updated recommendations for the treatment of systemic lupus erythematosus (SLE). The previous guideline for managing SLE in adults was published in 1999, said Lisa R. Sammaritano, MD, of the Hospital for Special Surgery in New York City, who led the project. At that time, “the recommended management for severe disease was high-dose steroid (eg, prednisone) plus an immunosuppressive agent, usually azathioprine or cyclophosphamide,” she told Medscape Medical News. “Since then, the spectrum of available therapies for SLE treatment has broadened considerably, and there have been important changes in our understanding of optimal use of rheumatology therapies, both new and old.” This new guideline, applicable to both adults and children, focuses on reaching and maintaining remission or lower disease activity and minimizing treatment-related toxicities. The guideline summary was posted last month on the ACR website, and ...
THURSDAY, June 5, 2025 (HealthDay News) — Some packages of organic ground beef sold at Whole Foods stores across the country may be contaminated with E. coli, federal officials have warned. The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) issued a public health alert Wednesday about one-pound packages of “ORGANIC RANCHER ORGANIC GROUND BEEF 85% LEAN 15% FAT.” The affected beef was produced May 22 and 23, 2025, and has “Use or Freeze By 06-19-25” or “Use or Freeze By 06-20-25” printed on the label. The packaging also includes the establishment number “EST. 4027” inside the USDA mark of inspection, CBS News reported. While this beef is no longer being sold in stores, officials say some may still be in customers’ homes. Anyone with this product should not eat it. “These products should be thrown away or returned to the place of purchase,” the alert stated. ...
Tianyi Medical announced on the evening of June 5 that the company recently received the ” Medical Device registration certificate involves two new products, namely a disposable continuous renal replacement therapy tube and a disposable hemodialysis tube. According to the announcement, the disposable continuous renal replacement therapy tubing consists of tubing, threaded pre-filled needles, etc., and is used as a blood and fluid channel during continuous renal replacement therapy (CRRT); the disposable hemodialysis tubing consists of arterial tubes, venous tubes, etc., and is used as a blood channel for hemodialysis and hemodiafiltration mode treatment of patients with acute and chronic renal failure. Both products are sterilized with ethylene oxide and are disposable products. According to information, Tianyi Medical is a high-tech enterprise mainly engaged in the research, development, production and sales of medical devices such as medical polymer consumables in the fields of blood purification and ward nursing. It is ...
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.